Research Report
Hotstocked.com has a complete research report available for DNDN stock.
Download DNDN report.
Research Report
Get the full report for FREE
| Date: | Aug 12, 2009 |
| Price: | Free |
| Pages: | 5 | | Document Type: | Adobe Acrobat Reader |
| | Download DNDN report |
| | |
| Example preview: |
|
News for Dendreon Co (DNDN)
|
|
|
News for Dendreon Corp.
(DNDN)
|
|
|
|
|
After Hours:
$ 28.00
|
-0.01
(-0.04%)
|
Volume: 14.26 k
|
7:47 PM EST Nov 20, 2009
|
|
|
|
|
|
| 8:30 AM |
Dendreon Receives FDA Acknowledgement of Complete Response - PR Newswire |
|
|
| 6:45 AM |
Unbiased Analysis on FITB, HCBK, ADSK, HBAN, FINL and DNDN Posted on WallStSense.com - Marketwire |
|
|
| 4:00 PM |
Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization - PR Newswire |
|
|
| 6:14 AM |
BenchmarkJournal.com Issues Independent Review on FINL, FSLR, EWBC, FITB, BARE and DNDN - Marketwire |
|
|
| 8:31 AM |
Dendreon Completes Submission of Biologics License Application for PROVENGE - PR Newswire |
|
|
| 7:30 AM |
Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET - PR Newswire |
|
|
| 7:30 AM |
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences - PR Newswire |
|
|
| 7:17 AM |
BID, DGX, FO, CNW, DNDN and LAMR Receiving Professional Financial Coverage from RothmanResearch.com - Marketwire |
|
|
| 2:47 PM |
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter - Business Wire |
|
|
| 6:39 AM |
AnalystChoice.com Brings You the Best Complimentary Research Report on DNDN, FINL, JASO, ARBA, FITB and EWBC - Marketwire |
|
|
| 12:59 PM |
Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors - PR Newswire |
|
|
| 6:14 AM |
TheFortuneFinancial.com Free Market Research on CAKE, ADSK, CLNE, AMZN, DNDN and DPTR - Marketwire |
|
|
| 11:01 AM |
Mentor Capital, Inc. Speaks on Cancer Investment with Long Island Investment Banking Group - Business Wire |
|
|
| 11:00 AM |
Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event - PR Newswire |
|
|
| 10:26 AM |
Deciphering CEL-SCI's H1N1 Flu Play - Baystreet.ca |
|
|
| 6:02 AM |
WallStSense.com Fundamental & Technical Coverage of CLNE, FITB, ADSK, DNDN, HBAN and AMCC - Marketwire |
|
|
| 9:06 AM |
Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead by ImmunoCellular Therapeutics - Business Wire |
|
|
| 8:38 AM |
Ahead of the Bell: Sunwin International Neutraceuticals - September 15, 2009 - Marketwire |
|
|
| 6:39 AM |
BenchmarkJournal.com Free Analyst Review for DNDN, FITB, ADTN, EWBC, SHLD and CATY - Marketwire |
|
|
| 5:43 PM |
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences - PR Newswire |
|
|
| 1:11 PM |
New Cancer Immunotherapy Index Posts 23% Gains Lead by Mentor Capital, Inc. and Oncothyreon - Business Wire |
|
|
| 7:30 AM |
Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009 - PR Newswire |
|
|
| 7:00 AM |
Dendreon Reports Second Quarter 2009 Financial Results - PR Newswire |
|
|
| 3:50 PM |
Dendreon Signs Lease for New Manufacturing Facility in Atlanta - PR Newswire |
|
|
| 7:31 AM |
Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET - PR Newswire |
|
|
|
|
Copyright © QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).
RT Realtime,
DL+ Realtime BATS,
EOD End Of Day,
PD Previous Day.
Market Data powered by QuoteMedia. Terms of Use.
|
|
|
|
|